|
Dr Diana Siew
Strategic Partnerships Lead, Auckland Bioengineering Institute, University of Auckland Diana Siew co-founded the Consortium for Medical Device Technologies (CMDT), the network underpinning NZ’s MedTech innovation ecosystem. She is a “weaver” in this system, connecting people and building partnerships to create new research and business opportunities. Diana leads several national initiatives that focus on the research translation and early stage start-up communities in the MedTech space including Te Titoki Mataora MedTech Research Translator and the Australia-NZ BioBridge. These programmes facilitate collaborative partnerships locally and internationally, and seeds the pipeline of new opportunities addressing health, social well-being and economic growth. She is also working on MedTech-iQ Aotearoa, a medical devices and digital health technology innovation hub for NZ and its Tamaki Makaurau Auckland regional hub.
|
|
Diana has been in the MedTech research innovation space since 2012. Her areas of expertise are in the early-stage commercialisation and research translation spaces. She leads the Auckland Bioengineering Institute’s Cloud9, an incubator space that nurtures early stage MedTech spin-outs. Diana has informally advised many start-ups and is on the MedTech Investment Committee of Return on Science, and Advisor of Callaghan Innovation’s HealthTech Activator and sits on the Board of Creative HQ and Pharmac. She is Strategic Partnerships Lead at the Auckland Bioengineering Institute
Te Titoki Mataora MedTech Research Translator : A Considered Strategy in Research Translation
NZ is now a country of medical devices and digital health technology start-ups with over 220 home grown companies. We started as a “blip” in this space 10 years ago so we should collectively celebrate what has been achieved. Our challenge in the 10 years is how we transition into a country of MedTech scale-ups to benefit our healthcare system and grow the country’s productivity with high value career pathways. Part of the solution lies in our ability to apply our research to unmet healthcare problems that actually meet the needs of the end-user be this clinicians, healthcare providers or the community. Another important consideration is improving equity in healthcare and working with our Māori and Pacific communities to co-design technologies that will improve equity in healthcare.
Our case study, Te Titoki Mataora (TTM) MedTech Research Translator is seeding start-ups in NZ with technologies that are responsive to the community which also have global reach, while building capability nationally in MedTech translation. It is an inclusive initiative supporting our innovation ecosystem. TTM is a $10M national initiative funded by MBIE and the University of Auckland with in-kind contributions from AUT, Universities of Canterbury and Otago, Callaghan Innovation and Te Whatu Ora Auckland, Waitemata and Capital & Coast Wellington Districts.
NZ is now a country of medical devices and digital health technology start-ups with over 220 home grown companies. We started as a “blip” in this space 10 years ago so we should collectively celebrate what has been achieved. Our challenge in the 10 years is how we transition into a country of MedTech scale-ups to benefit our healthcare system and grow the country’s productivity with high value career pathways. Part of the solution lies in our ability to apply our research to unmet healthcare problems that actually meet the needs of the end-user be this clinicians, healthcare providers or the community. Another important consideration is improving equity in healthcare and working with our Māori and Pacific communities to co-design technologies that will improve equity in healthcare.
Our case study, Te Titoki Mataora (TTM) MedTech Research Translator is seeding start-ups in NZ with technologies that are responsive to the community which also have global reach, while building capability nationally in MedTech translation. It is an inclusive initiative supporting our innovation ecosystem. TTM is a $10M national initiative funded by MBIE and the University of Auckland with in-kind contributions from AUT, Universities of Canterbury and Otago, Callaghan Innovation and Te Whatu Ora Auckland, Waitemata and Capital & Coast Wellington Districts.
